218 related articles for article (PubMed ID: 1703118)
1. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
[TBL] [Abstract][Full Text] [Related]
2. [Fate of polycythemia vera treated by radioactive phosphorus. Apropos of a series of 303 patients followed for 12 to 24 years].
Tubiana M; Attie E; Parmentier C
Nouv Presse Med; 1975 Jun; 4(24):1781-6. PubMed ID: 1161478
[TBL] [Abstract][Full Text] [Related]
3. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
Krańik W
Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
[TBL] [Abstract][Full Text] [Related]
4. Course and transformation of polycythaemia vera in relation to therapy.
Burger T; Schmelczer M; Molnár L; Pajor L; Koszorus S
Acta Med Hung; 1988; 45(1):97-113. PubMed ID: 3412864
[TBL] [Abstract][Full Text] [Related]
5. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases].
Sánchez Fayos J; Prieto E; Román A; Soto de Ozaeta C; Nevado I; Richart A; Chica E; Loscertales J; Calabuig T; Benítez J; Outeiriño J
Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422
[TBL] [Abstract][Full Text] [Related]
6. Busulfan versus 32P in polycythaemia vera.
Zittoun R
Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
[TBL] [Abstract][Full Text] [Related]
7. [Polycythaemia vera--diagnosis and therapy].
Lechner K; Geissler K; Gisslinger H
Wien Klin Wochenschr; 1999 Aug; 111(15):582-9. PubMed ID: 10483672
[TBL] [Abstract][Full Text] [Related]
8. Outcome of 259 patients with primary proliferative polycythaemia (PPP) and idiopathic thrombocythaemia (IT) treated in a regional nuclear medicine department with phosphorus-32--a 15 year review.
Balan KK; Critchley M
Br J Radiol; 1997 Nov; 70(839):1169-73. PubMed ID: 9536909
[TBL] [Abstract][Full Text] [Related]
9. [Radiophosphorus therapy of polycythemia vera].
Hör G; Pabst HW
Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
[No Abstract] [Full Text] [Related]
10. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
11. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
Parmentier C; Gardet P
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
[TBL] [Abstract][Full Text] [Related]
12. [Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].
Tesselaar ME; Wijermans PW; Metsaars JA; Gerrits WB; Haak HL
Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1900-2. PubMed ID: 8927166
[TBL] [Abstract][Full Text] [Related]
13. [Long-term follow-up of a patient with accidental phosphor 32 overdose].
Holy D; Caduff B; Kistler HJ
Schweiz Med Wochenschr; 1994 Oct; 124(42):1848-51. PubMed ID: 7973511
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis.
Randi ML; Fabris F; Visentin I; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
Rain JD
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of polycythemia. I--Using radiophosphorus with or without treatment in 483 patients over 65 years of age].
Najean Y; Rain JD; Goguel A; Grange MJ; Vigneron N; Dupuy E; Mougeot-Martin M
Ann Med Interne (Paris); 1998 Mar; 149(2):87-93. PubMed ID: 11490530
[TBL] [Abstract][Full Text] [Related]
18. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Ellis JT; Peterson P; Geller SA; Rappaport H
Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
[TBL] [Abstract][Full Text] [Related]
19. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
[TBL] [Abstract][Full Text] [Related]
20. Inter-relationship between polycythaemia vera, leukaemia and myeloid metaplasia.
Modan B
Clin Haematol; 1975 Jun; 4(2):427-39. PubMed ID: 1102196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
